NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

CrhoA.18283.a: AMP deaminase, putative

Target Characteristics

from organism: Cryptosporidium hominis
most recent status: cloned
center reference id: CrhoA.18283.a
is community request: True
associated disease:
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIB

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
CrhoA.18283.a.B1.GE35454 full length 1 438 GE35454
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

External Resources

Resource Reference ID
EuPathDB: CryptoDB:Chro.40214
OrthoMCL: OG5_126856
RefSeq: XP_667873.1
UniProt: Q5CLZ5

Enzyme & Pathway Information

Pathway Pathway ID EC Number
3.5.4.6

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MDAIRNCFQR FDRFNEKYNP FGSNLMRDIF LKYNNPIKGK YLAEITKEVI QDLKTTHYQF VEWRISVYGK DKSEWKTLAE WLYNNGLYCK HVRWIIQIPR LYNIFYKDGC VKTFSEMLEN IFSPLIEALI NPKDNPLIFI LLTNIVGWDT VDDESQISKY SMDNPNFCYP EYWRSGDNPP YSYWGFYLYS NIRVLNQLLY SRGLNPLMFR PHCGEAGKIS HLATMYLLAD SINHGILLKK TPVLQYLYYL KQIGIAVSPV SNNALFLELM KNPFPKFFNV GLNVSLSTDD PLIFHFTDES LLEEYSIASH IWKLNNIDLC EIARNSVLQS GFSPKYKASW LGVKNYSHLN KSLYNILNDL EPCEINDISR SNVPNIRIQF RKDMLKGEMD LINKYTVSID RIENAISIVK NLRLKNVSDN ISKEGVNRNS NSLMNNFP

NT Sequence
atggatgcaa ttaggaactg ttttcaaagg tttgatagat ttaacgagaa atataatcca ttcggttcta acctgatgag agatatattc ttgaaatata acaatccaat taagggaaaa tatcttgctg aaattacaaa ggaagtaatt caagatttaa aaactacaca ttatcaattt gtggaatgga gaatcagtgt ctacggtaaa gacaagagcg aatggaaaac tttagcagag tggctatata ataatggttt atattgtaaa catgtaagat ggatcattca gattccaaga ctttataata ttttttacaa agatgggtgc gttaaaacat tcagtgaaat gctcgaaaat atattttccc cattaataga agcattgatc aatccaaaag ataatcccct gatttttatt ttacttacta atattgttgg ttgggacaca gtagatgatg aaagccaaat aagtaagtat tcaatggata acccgaactt ttgttatcca gaatattgga gatcaggaga taacccacca tactcttatt ggggcttcta tctttatagt aatattcgag tgctaaatca acttttatac tctagaggtt taaatccatt gatgttcagg cctcattgtg gagaagctgg aaaaatctca cacttagcta caatgtattt attagctgat tctattaacc acggaatatt acttaaaaaa actccagtat tgcaatattt atactacttg aaacaaattg gcattgcagt ttctcctgtt tctaacaatg cattgttttt ggagttaatg aaaaatccat tcccaaagtt ttttaatgtt ggattaaatg tctcgctatc aactgatgat ccccttattt ttcactttac agatgaatct cttctcgaag agtattctat tgcctctcat atttggaaat tgaacaatat tgacctttgc gagatcgcga gaaattcggt tcttcagtct ggattttcac caaaatataa ggcaagttgg ttaggtgtga aaaactacag tcatttaaat aaatcactat ataatatttt aaatgatttg gaaccttgtg aaatcaacga tatttcgagg tcgaatgtcc caaacattag aatccagttt agaaaagata tgcttaaagg tgaaatggac ctcataaata agtatacagt ttcaattgat agaatcgaaa atgcaataag tattgtaaaa aatttaagat tgaaaaatgt ttccgataat ataagcaaag aaggagttaa tcgtaactct aattccttaa tgaataattt cccctaa

© 2023 Seattle Children's Research Institute. All rights reserved.